Jonas Schreiber

Cell-to-cell and organ-to-organ crosstalk in the pathogenesis of alcohol-associated liver disease

EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)

Epigenetic basis for monocyte dysfunction in patients with severe alcoholic hepatitis

The use of beta‐blockers is associated with the occurrence of acute kidney injury in severe alcoholic hepatitis